These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37123205)

  • 21. Hematopoietic PI3Kδ deficiency aggravates murine atherosclerosis through impairment of regulatory T cells.
    Zierden M; Berghausen EM; Gnatzy-Feik L; Millarg C; Picard FSR; Kiljan M; Geißen S; Polykratis A; Zimmermann L; Nies RJ; Pasparakis M; Baldus S; Valasarajan C; Pullamsetti SS; Winkels H; Vantler M; Rosenkranz S
    JCI Insight; 2024 Oct; ():. PubMed ID: 39378110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PI3Kδ Pathway Dysregulation and Unique Features of Its Inhibition by Leniolisib in Activated PI3Kδ Syndrome and Beyond.
    Cant AJ; Chandra A; Munro E; Rao VK; Lucas CL
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):69-78. PubMed ID: 37777067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated PI3Kδ specifically perturbs mouse Treg homeostasis and function leading to immune dysregulation.
    Singh AK; Qureshah FA; Drow T; Hou B; Rawlings DJ
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8
    Yoon YN; Lee E; Kwon YJ; Gim JA; Kim TJ; Kim JS
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ, IL-12/IL-4, IL-5 balance.
    Xiong S; Guo R; Yang Z; Xu L; Du L; Li R; Xiao F; Wang Q; Zhu M; Pan X
    Immunobiology; 2015 Nov; 220(11):1284-91. PubMed ID: 26224246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential PI3Kδ Signaling in CD4
    Ahmad S; Abu-Eid R; Shrimali R; Webb M; Verma V; Doroodchi A; Berrong Z; Samara R; Rodriguez PC; Mkrtichyan M; Khleif SN
    Cancer Res; 2017 Apr; 77(8):1892-1904. PubMed ID: 28108509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis.
    Ten Berge B; Paats MS; Bergen IM; van den Blink B; Hoogsteden HC; Lambrecht BN; Hendriks RW; Kleinjan A
    Rheumatology (Oxford); 2012 Jan; 51(1):37-46. PubMed ID: 22075064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Establishment and identification of a C57B/6 mouse sarcoidosis granuloma model].
    Huang Y; Lu CZ; Wang CC; Jiang Y; Wang XY; Duan YY
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):587-91. PubMed ID: 24252735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T cells inhibit acute IFN-γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10.
    Sojka DK; Fowell DJ
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18336-41. PubMed ID: 22025707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired survival of regulatory T cells in pulmonary sarcoidosis.
    Broos CE; van Nimwegen M; Kleinjan A; ten Berge B; Muskens F; in 't Veen JC; Annema JT; Lambrecht BN; Hoogsteden HC; Hendriks RW; Kool M; van den Blink B
    Respir Res; 2015 Sep; 16(1):108. PubMed ID: 26376720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.
    Christophi GP; Caza T; Curtiss C; Gumber D; Massa PT; Landas SK
    Exp Mol Pathol; 2014 Jun; 96(3):393-9. PubMed ID: 24768588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Roles of T Helper 1, T Helper 17 and Regulatory T Cells in the Pathogenesis of Sarcoidosis.
    Mortaz E; Rezayat F; Amani D; Kiani A; Garssen J; Adcock IM; Velayati A
    Iran J Allergy Asthma Immunol; 2016 Aug; 15(4):334-339. PubMed ID: 27921415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.
    Isoyama S; Mori S; Sugiyama D; Kojima Y; Tada Y; Shitara K; Hinohara K; Dan S; Nishikawa H
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Liuweibuqi capsules on CD4
    Wang CY; Ding HZ; Tang X; Li ZG
    J Thorac Dis; 2018 May; 10(5):2700-2711. PubMed ID: 29997932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.
    Piddock RE; Loughran N; Marlein CR; Robinson SD; Edwards DR; Yu S; Pillinger GE; Zhou Z; Zaitseva L; Auger MJ; Rushworth SA; Bowles KM
    Blood Cancer J; 2017 Mar; 7(3):e539. PubMed ID: 28282033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL23R on myeloid cells is involved in murine pulmonary granuloma formation.
    Schreiber T; Falk-Paulsen M; Kuiper J; Aden K; Noth R; Gisch N; Schreiber S; Rosenstiel P; Bewig B
    Exp Lung Res; 2021 Sep; 47(7):344-353. PubMed ID: 34405744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of PI3Kδ inhibitor CAL-101 on myeloma cell lines and preliminary study of synergistic effects with other new drugs].
    Zhang Q; Xia B; Qu F; Yuan T; Guo S; Zhao W; Li Q; Yang H; Wang Y; Zhang Y
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):926-30. PubMed ID: 25339332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.